PMGC Holdings ELAB
NASDAQ ELAB
$4.70 +0.08 (+1.72%)
As of: Sep 10, 2026 · 12:55 PM EDT

PMGC Holdings (ELAB) Operating Expenses (2022 - 2026)

PMGC Holdings' (ELAB) quarterly Operating Expenses came in at $4.2 million in Q2 2026, up 18.22% quarter-over-quarter from $3.6 million in Q1 2026.

Analysis

PMGC Holdings (ELAB) Operating Expenses (2022 - 2026) Analysis & Trends

PMGC Holdings has disclosed Operating Expenses across 5 years of filings, most recently posting $4.2 million for Q2 2026.

  • In Q2 2026, Operating Expenses changed N/A year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $12.6 million (changed N/A YoY), while the FY2025 annual figure was $7.1 million, changed N/A from the prior year.
  • Operating Expenses came in at $4.2 million for Q2 2026 at PMGC Holdings, up from $3.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $709.5 million in Q3 2022 to a low of -$1.5 billion in Q4 2022.
  • Average Operating Expenses over 5 years is -$56.6 million, with a median of $1.8 million recorded in 2024.
  • Year-over-year, Operating Expenses sank 99.84% in 2023 and jumped 125.36% in 2024.
  • Over 5 years, Operating Expenses stood at -$1.5 billion in 2022, then jumped by 100.11% to $1.5 million in 2023, then dropped by 14.84% to $1.3 million in 2024, then soared by 96.01% to $2.6 million in 2025, then jumped by 63.6% to $4.2 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $4.2 million in Q2 2026, $3.6 million in Q1 2026, and $2.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.09 Bn 192.10 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 179.75 Bn 176.57 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 131.11 Bn 123.26 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.77 Bn 73.78 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.45 Bn 55.27 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.60 Bn 48.46 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.36 Bn 30.06 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.72 Bn 30.44 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.09 Bn 29.09 Bn 1.16 Mn 367.83 Mn
10 PMGC Holdings 2.29 Mn -16.50 Mn 385,691.00 4.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.21 Mn
Mar 31, 2026 3.56 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.28 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.85 Mn
Mar 31, 2024 2.13 Mn
Dec 31, 2023 1.54 Mn
Sep 30, 2023 1.15 Mn
Jun 30, 2023 1.26 Mn
Mar 31, 2023 944,776.00
Dec 31, 2022 -1.47 Bn
Sep 30, 2022 709.53 Mn